Subsequently, Cervia et al. further revealed that a significant increase in SARS-CoV-2 S protein-specific serum IgG and IgA antibody production develops in severe COVID-19 patients after symptom onset, with very high serum IgA titers correlated with severe acute respiratory distress syndrome [15]. This evidence concerns the gene PROS1 and COVID-19.